Holen Sie sich die Stockscreener-App
0.528
0.56%
-0.003
Handel nachbörslich:
.53
0.002
+0.38%
Schlusskurs vom Vortag:
$0.531
Offen:
$0.539
24-Stunden-Volumen:
903.82K
Relative Volume:
0.49
Marktkapitalisierung:
$25.29M
Einnahmen:
$3.04M
Nettoeinkommen (Verlust:
$-33.97M
KGV:
-0.397
EPS:
-1.33
Netto-Cashflow:
$-52.47M
1W Leistung:
-3.95%
1M Leistung:
-18.01%
6M Leistung:
-71.30%
1J Leistung:
-80.44%
1-Tages-Spanne:
$0.5228
$0.57
1-Wochen-Bereich:
$0.49
$0.5765
52-Wochen-Spanne:
$0.387
$3.75
Rani Therapeutics Holdings Inc Stock (RANI) Company Profile
Firmenname
Rani Therapeutics Holdings Inc
Sektor
Branche
Telefon
(408) 457-3700
Adresse
2051 RINGWOOD AVENUE, SAN JOSE
Vergleichen Sie RANI mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RANI
Rani Therapeutics Holdings Inc
|
0.528 | 25.43M | 3.04M | -33.97M | -52.47M | -1.33 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Rani Therapeutics Holdings Inc Stock (RANI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-08-02 | Eingeleitet | Oppenheimer | Outperform |
| 2024-06-14 | Eingeleitet | Maxim Group | Buy |
| 2024-06-13 | Eingeleitet | Rodman & Renshaw | Buy |
| 2023-04-17 | Fortgesetzt | BTIG Research | Buy |
| 2022-10-11 | Eingeleitet | UBS | Buy |
| 2022-07-27 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-06-13 | Eingeleitet | Wedbush | Outperform |
Alle ansehen
Rani Therapeutics Holdings Inc Aktie (RANI) Neueste Nachrichten
Can you recover from losses in Rani Therapeutics Holdings Inc.July 2025 Selloffs & Verified Trade Idea Suggestions - Newser
Has Rani Therapeutics Holdings Inc. found a price floorTake Profit & Weekly High Conviction Trade Ideas - Newser
What does recent volatility data suggest for Rani Therapeutics Holdings Inc.July 2025 Short Interest & Safe Capital Growth Trade Ideas - Newser
What momentum shifts mean for Rani Therapeutics Holdings Inc.Dividend Hike & Weekly High Return Stock Forecasts - Newser
Visual analytics tools that track Rani Therapeutics Holdings Inc. performance [Day Trade]Low Risk Investment Opportunities - Newser
Rani Therapeutics Reports Q2 2025 Financial Results - TipRanks
Why Rani Therapeutics Holdings Inc. stock attracts strong analyst attentionLong-Term Safety Investment Analysis Report - Newser
Will Rani Therapeutics Holdings Inc. benefit from macro trendsFree Opportunity Map for Daily Stock Trading - Newser
Comparing Rani Therapeutics Holdings Inc. in custom built stock radarsFree Swing Trade Entry With Volume Triggers - Newser
News impact scoring models applied to Rani Therapeutics Holdings Inc.Free Reliable Alerts for Daily Stock Movers - Newser
RANI: Second Quarter Financial Results - MSN
How institutional ownership impacts Rani Therapeutics Holdings Inc. stockMarket Forecast Summary Over Multi-Year Period - Newser
Automated trading signals detected on Rani Therapeutics Holdings Inc.Price Action Trading with Volume Confirmation - Newser
How Rani Therapeutics Holdings Inc. stock performs during market volatilityFree Breakout Momentum Picks With Protection - Newser
Will Rani Therapeutics Holdings Inc. rebound enough to break evenDaily Pattern Analysis with Return Forecast - Newser
Developing predictive dashboards with Rani Therapeutics Holdings Inc. dataShort-Term Price Breakout Signal Analysis - Newser
Bollinger Bands Show Potential Breakout in Rani Therapeutics Holdings Inc.Low Risk High Return Opportunities Identified - metal.it
Ranking Rani Therapeutics Holdings Inc. among high performing stocks via toolsSmart Risk Entry Zone Technical Analysis - Newser
How hedge fund analytics apply to Rani Therapeutics Holdings Inc. stockFree Investment Plan With Growth Optimization - Newser
Strategies to average down on Rani Therapeutics Holdings Inc.Low Risk Trade Timing with Analysis Metrics - Newser
Rani Therapeutics Files $200 Million Mixed Shelf - MarketScreener
Rani (RANI) Q2 Net Loss Improves 16% - Nasdaq
Rani Therapeutics Reports Second Quarter 2025 Financial Results; Provides Corporate Update - GlobeNewswire
Rani's Oral GLP-1/GLP-2 Obesity Drug Shows Breakthrough Results, Phase 1 Trial Coming in 2025 - Stock Titan
What moving averages say about Rani Therapeutics Holdings Inc.Free Daily Momentum Screener With Alerts - Newser
Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Sees Large Growth in Short Interest - Defense World
What technical models suggest about Rani Therapeutics Holdings Inc.’s comebackMulti-Year Signal Summary and Entry Timing - Newser
What is Rani Therapeutics Holdings Inc. company’s growth strategyOutstanding capital returns - Jammu Links News
When is Rani Therapeutics Holdings Inc. stock expected to show significant growthExceptional financial outcomes - Jammu Links News
What is the dividend policy of Rani Therapeutics Holdings Inc. stockMaximize portfolio value with expert tips - Jammu Links News
Is Rani Therapeutics Holdings Inc. stock overvalued or undervaluedCapitalize on market trends with expert guidance - Jammu Links News
What drives Rani Therapeutics Holdings Inc. stock priceMarket-leading growth rates - Jammu Links News
Finanzdaten der Rani Therapeutics Holdings Inc-Aktie (RANI)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):